Long-Term Safety of Tocilizumab in Patients with Rheumatoid Arthritis following a Mean Treatment Duration of 3.9 Years Haraoui, B., Sebba, A., Rubbert-Roth, A., Scali, J., Alten, R., Kremer, J., Pitts, L., Vernon, E., van Vollenhoven, R., Genovese, M. J RHEUMATOL PUBL CO. 2014: 1508

View details for Web of Science ID 000338923700166